rosiglitazone has been researched along with Sensitivity and Specificity in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 22 (62.86) | 29.6817 |
| 2010's | 13 (37.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernandez, AV; Ioannidis, JP; Kattan, MW; Walker, E | 1 |
| Aberra, FN; Chuai, S; Ellenberg, JH; Lewis, JD; Lichtenstein, GR; Nessel, L | 1 |
| Douglas, GT; Jenkins, RG; O'Maille, G; Pai, SM; Tao, X | 1 |
| He, JG; Lu, XH; Lv, GP; Si, SY; Zhang, H; Zhao, BH; Zheng, ZH | 1 |
| Dogan-Topal, B; Ozkan, SA; Tuncel, S | 1 |
| Al Azzam, KM; Makahleah, A; Mansor, SM; Saad, B | 1 |
| Bonato, PS; Calixto, LA | 1 |
| Attia, KA; El-Din, MM; Kaddah, MM; Nassar, MW | 1 |
| Bartošová, Z; Jirovský, D; Maier, V; Skopalová, J | 1 |
| Chen, L; Ma, A; Shen, M; Zhou, Z | 1 |
| Frazier, SA; Guerrero, TA; McKemie, DS; Rodriguez, CO; Skorupski, KA | 1 |
| Bok, SM; Chung, MJ; Han, YM; Jin, GY; Kim, SR; Lee, YC; Yoon, KH | 1 |
| Chen, L; Chen, X; Duan, X; Hu, J; Liu, J; Ma, L; Tang, M; Wang, X; Ye, X; Zheng, H | 1 |
| Foti, RS; Rock, DA; VandenBrink, BM; Wahlstrom, JL; Wienkers, LC | 1 |
| Aroeira, LS; González-Mateo, GT; López-Cabrera, M; Ortiz, A; Ruiz-Ortega, M; Selgas, R | 1 |
| Belgorosky, D; Eiján, AM; Langle, Y; Lodillinsky, C; Sandes, EO | 1 |
| Bakris, G; Freed, MI; Heise, M; Porter, LE; Viberti, G; Weston, WM | 1 |
| Grossman, E | 1 |
| Bagool, MA; Deo, AA; Kolte, BL; Raut, BB; Shinde, DB | 2 |
| Barnett, AH; Grant, PJ; Hitman, GA; Mather, H; Pawa, M; Robertson, L; Trelfa, A | 1 |
| Benjamin, B; Mamidi, RN; Ramesh, M; Srinivas, NR | 1 |
| Desai-Krieger, D; Lin, ZJ; Shum, L | 1 |
| Frye, RF; Hruska, MW | 1 |
| Adeli, K; Leung, N; Lewis, GF; Naples, M; Szeto, L; Uffelman, K | 1 |
| Belvisi, MG; Birrell, MA; Leonard, T; McCluskie, K; Patel, HJ; Wong, S; Yacoub, MH | 1 |
| Kim, KA; Park, JY | 1 |
| Chen, KX; Jiang, HL; Luo, HB; Shen, JH; Shen, X; Ye, F; Zhang, ZS | 1 |
| Averbukh, Z; Berman, S; Efrati, S; Feldman, L; Rapoport, M; Weissgarten, J | 1 |
| Duan, LF; He, J; Hu, YF; Li, Z; Liu, J; Tan, ZR; Tu, JH; Wang, D; Wang, LS; Yao, YM; Zhang, W; Zhou, HH | 1 |
| Chen, Y; Tian, Y; Zhang, L; Zhang, Z | 1 |
| Li, J; Sun, X; Wang, N; Xu, F; Yang, C; Zhang, Z | 1 |
| Hong, LZ; Hsieh, PS | 1 |
| Fowles, S; Muxlow, AM; Russell, P | 1 |
| Radhakrishna, T; Satyanarayana, A; Satyanarayana, J | 1 |
2 review(s) available for rosiglitazone and Sensitivity and Specificity
| Article | Year |
|---|---|
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.
Topics: Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Incidence; Male; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Rare Diseases; Reproducibility of Results; Risk Assessment; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones | 2008 |
Rosiglitazone reduces blood pressure and urinary albumin excretion in type 2 diabetes: G Bakris et al.
Topics: Albuminuria; Blood Pressure Determination; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Hypoglycemic Agents; Kidney Failure, Chronic; Male; Prognosis; Risk Assessment; Risk Factors; Rosiglitazone; Sensitivity and Specificity; Thiazoles; Thiazolidinediones | 2003 |
3 trial(s) available for rosiglitazone and Sensitivity and Specificity
| Article | Year |
|---|---|
Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis.
Topics: Colitis, Ulcerative; Fibrinolytic Agents; Humans; Hypoglycemic Agents; Placebos; Remission Induction; ROC Curve; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones; Treatment Outcome | 2008 |
Rosiglitazone reduces urinary albumin excretion in type II diabetes.
Topics: Administration, Oral; Aged; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Kidney Function Tests; Male; Middle Aged; Reference Values; Rosiglitazone; Sensitivity and Specificity; Thiazoles; Thiazolidinediones; Treatment Outcome | 2003 |
Sensitive and selective liquid chromatography-mass spectrometry method for the quantification of rosiglitazone in human plasma.
Topics: Administration, Oral; Adult; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Hypoglycemic Agents; Male; Reference Standards; Reference Values; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Thiazolidinediones | 2007 |
30 other study(ies) available for rosiglitazone and Sensitivity and Specificity
| Article | Year |
|---|---|
An improved LC-ESI-MS-MS method for simultaneous quantitation of rosiglitazone and N-desmethyl rosiglitazone in human plasma.
Topics: Calibration; Chromatography, Liquid; Drug Stability; Humans; Hypoglycemic Agents; Reference Standards; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Thiazolidinediones | 2008 |
Impacts of different promoters on the mammalian one-hybrid assay for detecting nuclear receptor agonists.
Topics: Animals; Bezafibrate; Cells, Cultured; Chenodeoxycholic Acid; Drug Discovery; Genetic Vectors; HeLa Cells; High-Throughput Screening Assays; Humans; Hydrocarbons, Fluorinated; Ligands; Mice; NIH 3T3 Cells; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Promoter Regions, Genetic; Pyrimidines; Rosiglitazone; Sensitivity and Specificity; Structure-Activity Relationship; Sulfonamides; Thiazolidinediones; Two-Hybrid System Techniques | 2010 |
Anodic voltammetric behavior and determination of rosiglitazone in pharmaceutical dosage forms and biological fluids on solid electrode.
Topics: Carbon; Dosage Forms; Electrochemistry; Electrodes; High-Throughput Screening Assays; Humans; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Rosiglitazone; Sensitivity and Specificity; Surface Properties; Thiazolidinediones | 2010 |
Hollow fiber liquid-phase microextraction for the determination of trace amounts of rosiglitazone (anti-diabetic drug) in biological fluids using capillary electrophoresis and high performance liquid chromatographic methods.
Topics: Chemical Fractionation; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Ethers; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Linear Models; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Sodium Chloride; Thiazolidinediones | 2010 |
Simultaneous determination of rosiglitazone and its metabolites in rat liver microsomal fraction using hollow-fiber liquid-phase microextraction for sample preparation.
Topics: Animals; Biotransformation; Chemical Fractionation; Chromatography, Liquid; Hypoglycemic Agents; Liver Extracts; Male; Microsomes, Liver; Rats; Rats, Wistar; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Solvents; Thiazolidinediones | 2010 |
Two different spectrofluorimetric methods for simultaneous determination of gemfibrozil and rosiglitazone in human plasma.
Topics: Buffers; Calibration; Gemfibrozil; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; In Vitro Techniques; Reference Standards; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Solutions; Spectrometry, Fluorescence; Thiazolidinediones | 2010 |
Electrochemical characterization of repaglinide and its determination in human plasma using liquid chromatography with dual-channel coulometric detection.
Topics: Carbamates; Chromatography, High Pressure Liquid; Colorimetry; Electrochemical Techniques; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Linear Models; Piperidines; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones | 2010 |
Simultaneous determination and pharmacokinetic study of metformin and rosiglitazone in human plasma by HPLC-ESI-MS.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Least-Squares Analysis; Male; Metformin; Phenformin; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Thiazolidinediones | 2011 |
Evaluation of an extractionless high-performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of rosiglitazone in canine plasma.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Carboplatin; Chromatography, High Pressure Liquid; Dog Diseases; Dogs; Female; Half-Life; Male; Neoplasms; Rosiglitazone; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazolidinediones | 2011 |
Effectiveness of rosiglitazone on bleomycin-induced lung fibrosis: Assessed by micro-computed tomography and pathologic scores.
Topics: Animals; Bleomycin; Disease Models, Animal; Feasibility Studies; Female; Humans; Mice; Mice, Inbred C57BL; Prognosis; Pulmonary Fibrosis; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Development and validation of a UPLC-MS/MS method for quantification of SKLB010, an investigational anti-inflammatory compound, and its application to pharmacokinetic studies in beagle dogs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Calibration; Chromatography, Liquid; Dogs; Drug Stability; Guideline Adherence; Guidelines as Topic; Methanol; Models, Biological; Reference Standards; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Thiazolidinediones; Water | 2011 |
Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrate.
Topics: Acetates; Amodiaquine; Aryl Hydrocarbon Hydroxylases; Binding Sites; Carbamates; Cyclopropanes; Cytochrome P-450 CYP2C8; Drug Interactions; Humans; Microsomes, Liver; Paclitaxel; Piperidines; Quinolines; Rosiglitazone; Sensitivity and Specificity; Substrate Specificity; Sulfides; Thiazolidinediones | 2011 |
Pharmacological modulation of peritoneal injury induced by dialysis fluids: is it an option?
Topics: Animals; Celecoxib; Dialysis Solutions; Disease Models, Animal; Enalapril; Female; Humans; Male; Mice; Peritoneal Dialysis; Peritoneal Diseases; Peritoneum; Pharmaceutical Preparations; Prospective Studies; Pyrazoles; Rats; Rosiglitazone; Sensitivity and Specificity; Sulfonamides; Thiazolidinediones | 2012 |
Role of peroxisome proliferator activated receptor-gamma in bacillus Calmette-Guérin bladder cancer therapy.
Topics: Administration, Intravesical; Analysis of Variance; Animals; Blotting, Western; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Gene Expression Regulation; Humans; Immunohistochemistry; Mice; Mice, Inbred Strains; Mycobacterium bovis; Peroxisomes; PPAR gamma; Reference Values; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones; Tumor Burden; Urinary Bladder Neoplasms | 2012 |
Liquid chromatographic method for the determination of rosiglitazone in human plasma.
Topics: Chromatography, High Pressure Liquid; Humans; Hypoglycemic Agents; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Thiazolidinediones | 2003 |
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
Topics: Adult; Aged; Asia; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Placebos; Rosiglitazone; Sensitivity and Specificity; Thiazoles; Thiazolidinediones; Treatment Outcome | 2003 |
Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standard.
Topics: Chromatography, High Pressure Liquid; Humans; Hypoglycemic Agents; Reference Standards; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Thiazolidinediones | 2003 |
Simultaneous determination of glipizide and rosiglitazone unbound drug concentrations in plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Dialysis; Drug Stability; Glipizide; Humans; Hypoglycemic Agents; Quality Control; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Thiazolidinediones | 2004 |
Simultaneous determination of metformin in combination with rosiglitazone by reversed-phase liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Metformin; Reference Standards; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Thiazolidinediones | 2004 |
Simplified method for determination of rosiglitazone in human plasma.
Topics: Chromatography, High Pressure Liquid; Humans; Hypoglycemic Agents; Reference Standards; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrometry, Fluorescence; Thiazolidinediones | 2004 |
Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance.
Topics: Analysis of Variance; Animals; Blood Glucose; Cricetinae; Dietary Fats; Disease Models, Animal; Glucose Clamp Technique; Hypoglycemic Agents; Insulin Resistance; Intestinal Absorption; Intestinal Mucosa; Lipoproteins; Male; Mesocricetus; Probability; Random Allocation; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones | 2004 |
PPAR-gamma agonists as therapy for diseases involving airway neutrophilia.
Topics: Administration, Oral; Airway Resistance; Analysis of Variance; Animals; Bronchial Hyperreactivity; Disease Models, Animal; Inflammation Mediators; Lipopolysaccharides; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neutrophils; Peroxisome Proliferator-Activated Receptors; Probability; Reference Values; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones | 2004 |
Simple and extractionless high-performance liquid chromatographic determination of rosiglitazone in human plasma and application to pharmacokinetics in humans.
Topics: Acetates; Acetonitriles; Chromatography, High Pressure Liquid; Humans; Hypoglycemic Agents; Indicators and Reagents; Perchlorates; Rosiglitazone; Sensitivity and Specificity; Spectrometry, Fluorescence; Thiazolidinediones | 2004 |
The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation.
Topics: Animals; Biological Assay; Chlorocebus aethiops; Computer Simulation; COS Cells; Crystallography, X-Ray; Dipeptides; Models, Molecular; Molecular Structure; PPAR gamma; Rosiglitazone; Sensitivity and Specificity; Structure-Activity Relationship; Surface Plasmon Resonance; Thiazolidinediones; Time Factors; Two-Hybrid System Techniques | 2006 |
Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats.
Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Diabetes Mellitus; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Mesangium; In Situ Nick-End Labeling; PPAR gamma; Pregnancy; Pregnancy, Animal; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Risk Factors; Rosiglitazone; Sensitivity and Specificity; Statistics, Nonparametric; Streptozocin; Thiazolidinediones; Transforming Growth Factor beta | 2006 |
Simultaneous determination of metformin and rosiglitazone in human plasma by liquid chromatography/tandem mass spectrometry with electrospray ionization: application to a pharmacokinetic study.
Topics: Chromatography, Liquid; Humans; Hypoglycemic Agents; Metformin; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Thiazolidinediones | 2007 |
Simultaneous determination of dipyridamole and salicylic acid in human plasma by high performance liquid chromatography-mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Diazepam; Dipyridamole; Humans; Reproducibility of Results; Rosiglitazone; Salicylic Acid; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Thiazolidinediones | 2008 |
Augmentation of nitric oxide is crucial for the time-dependent effects of rosiglitazone on blood pressure and baroreflex function in rats.
Topics: Administration, Oral; Animals; Arteries; Atropine Derivatives; Autonomic Nervous System; Baroreflex; Blood Glucose; Blood Pressure; Body Weight; Heart Rate; Insulin; Insulin Resistance; Linear Models; Lipids; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Propranolol; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones; Time Factors | 2008 |
Automated high-performance liquid chromatography method for the determination of rosiglitazone in human plasma.
Topics: Automation; Chromatography, High Pressure Liquid; Humans; Hypoglycemic Agents; Reference Standards; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrometry, Fluorescence; Thiazoles; Thiazolidinediones | 2001 |
LC determination of rosiglitazone in bulk and pharmaceutical formulation.
Topics: Chromatography, Liquid; Hypoglycemic Agents; Pharmaceutical Preparations; Reference Standards; Reproducibility of Results; Rosiglitazone; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Thiazoles; Thiazolidinediones | 2002 |